fintopic.
Docs Get the API

Moderna stock plummets after vaccine trial data leak

6 statements from 6 sources, Oct 22, 2026 19:04 UTC to Oct 23, 2026 08:47 UTC
News
Updated
Front page

Statements (6)

  1. Bearish

    Moderna's stock price dropped after preliminary data on its skin cancer vaccine failed to meet high investor expectations.

    manager-magazin.deHigh importance
  2. Bearish

    Moderna shares fell 17% after leaked trial data showed promising results for its cancer vaccine treatment.

    thestreet.comHigh importance
  3. Bearish

    Moderna stock price sank after vaccine data leak

    barchart.comHigh importance
  4. Bearish

    Moderna shares fell more than 25% on the news of cancer vaccine data.

    theglobeandmail.comHigh importance
  5. Bearish

    Moderna, a pharmaceutical company, lost nearly 25% of its stock price on Wall Street following a leak on social media.

    di.seHigh importance
  6. Bearish

    Moderna's stock price plummeted following the release of cancer-vaccine study data on social media.

    wsj.comHigh importance